References
- Abrahamson M, Olafsson I, Palsdottir A, Ulvsback M, Lundwall A, Jensson O, Grubb A. 1990. Structure and expression of the human cystatin C gene. Biochem J 268: 287-294. https://doi.org/10.1042/bj2680287
- Atkins C, Bonagura J, Ettinger S, Fox P, Gordon S, Haggstrom J, Hamlin R, Keene B, Luis-Fuentes V, Stepien R. 2009. Guidelines for the diagnosis and treatment of canine chronic valvular heart disease. J Vet Intern Med 23: 1142-1150. https://doi.org/10.1111/j.1939-1676.2009.0392.x
- Atkins CE, Haggstrom J. 2012. Pharmacologic management of myxomatous mitral valve disease in dogs. J Vet Cardiol 14: 165-184. https://doi.org/10.1016/j.jvc.2012.02.002
- Brown S, Atkins C, Bagley R, Carr A, Cowgill L, Davidson M, Egner B, Elliott J, Henik R, Labato M, Littman M, Polzin D, Ross L, Snyder P, Stepien R. 2007. Guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats. J Vet Intern Med 21: 542-558. https://doi.org/10.1111/j.1939-1676.2007.tb03005.x
- Brown S, Elliott J, Francey T, Polzin D, Vaden S. 2013. Consensus recommendations for standard therapy of glomerular disease in dogs. J Vet Intern Med 27 (Suppl 1): S27-43. https://doi.org/10.1111/jvim.12230
- Brown S. 2013. Introduction from the International Renal Interest Society. J Vet Intern Med 27 (Suppl 1): S1.
- Currie G, Delles C. 2013. Proteinuria and its relation to cardiovascular disease. International journal of nephrology and renovascular disease. Int J Nephrol Renovasc Dis 21: 13-24. https://doi.org/10.2147/IJNRD.S40522
- Dharnidharka VR, Kwon C, Stevens G. 2002. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 40: 221-226. https://doi.org/10.1053/ajkd.2002.34487
- Drum MG, Marcellin-Little DJ, Davis MS. 2015. Principles and applications of therapeutic exercises for small animals. Vet Clin North Am Small Anim Pract 45: 73-90. https://doi.org/10.1016/j.cvsm.2014.09.005
- Ellison DH. 2001. Diuretic therapy and resistance in congestive heart failure. Cardiology 96: 132-143. https://doi.org/10.1159/000047397
- Elmahdy MF, Allehyani NM, Shehata NM, Alanazi MO. 2021. Diuretics increase Blood Creatinine in the Treatment of Hypertension. Medico-Legal Update 21: 780-785. https://doi.org/10.37506/mlu.v21i2.2777
- Felker GM. 2012. Loop diuretics in heart failure. Heart Fail Rev 17: 305-311. https://doi.org/10.1007/s10741-011-9245-3
- Ghys L, Paepe D, Smets P, Lefebvre H, Delanghe J, Daminet S. 2014. Cystatin C: a new renal marker and its potential use in small animal medicine. J Vet Intern Med 28: 1152-1164. https://doi.org/10.1111/jvim.12366
- Hall J, Yerramilli M, Obare E, Yerramilli M, Almes K, Jewell D. 2016. Serum concentrations of symmetric dimethylarginine and creatinine in dogs with naturally occurring chronic kidney disease. J Vet Intern Med 30: 794-802. https://doi.org/10.1111/jvim.13942
- Hall J, Yerramilli M, Obare E, Yerramilli M, Jewell D. 2014. Comparison of serum concentrations of symmetric dimethylarginine and creatinine as kidney function biomarkers in cats with chronic kidney disease. J Vet Intern Med 28: 1676-1683. https://doi.org/10.1111/jvim.12445
- Hansson K, Haggstrom J, Kvart C, Lord P. 2002. Left atrial to aortic root indices using two-dimensional and M-mode echocardiography in cavalier King Charles spaniels with and without left atrial enlargement. Vet Radiol Ultrasound 43: 568-575. https://doi.org/10.1111/j.1740-8261.2002.tb01051.x
- Herget-Rosenthal S, Bokenkamp A, Hofmann W. 2007. How to estimate GFR-serum creatinine, serum cystatin C or equations? Clin Biochem 40: 153-161. https://doi.org/10.1016/j.clinbiochem.2006.10.014
- Huerta A, Lopez B, Ravassa S, San Jose G, Querejeta R, Beloqui O, Zubillaga E, Rabago G, Brugnolaro C, Diez J, Gonzalez A. 2016. Association of cystatin C with heart failure with preserved ejection fraction in elderly hypertensive patients: potential role of altered collagen metabolism. J Hypertens 34: 130-138. https://doi.org/10.1097/HJH.0000000000000757
- Iwasa N, Takashima S, Iwasa T, Iwasa K, Suzuki T, Kobatake Y, Kitagawa H, Nishii N. 2018. Serum cystatin C concentration measured routinely is a prognostic marker for renal disease in dogs. Res Vet Sci 119: 122-126. https://doi.org/10.1016/j.rvsc.2018.06.014
- Keene BW, Atkins CE, Bonagura JD, Fox PR, Haggstrom J, Fuentes VL, yama MA, Rush JE, Stepien R, Uechi M. 2019. ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs. J Vet Intern Med 33: 1127-1140. https://doi.org/10.1111/jvim.15488
- Koenig W, Twardella D, Brenner H, Rothenbacher D. 2005. Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate. Clin Chem 51: 321-327. https://doi.org/10.1373/clinchem.2004.041889
- Laterza OF, Price CP, Scott MG. 2002. Cystatin C: an improved estimator of glomerular filtration rate? Clin Chem 48: 699-707. https://doi.org/10.1093/clinchem/48.5.699
- Liang KV, Williams AW, Greene EL, Redfield MM. 2008. Acute decompensated heart failure and the cardiorenal syndrome. Crit Care Med 36 (Suppl 1): S75-88. https://doi.org/10.1097/01.CCM.0000296270.41256.5C
- Luo J, Wang LP, Hu HF, Zhang L, Li YL, Ai LM, Mu HY, Wang K. 2015. Cystatin C and cardiovascular or all-cause mortality risk in the general population: a meta-analysis. Clin Chim Acta 450: 39-45. https://doi.org/10.1016/j.cca.2015.07.016
- Martinelli E, Crosara S, Locatelli C, Zanaboni AM, Brambilla P, Quintavalla C. 2020. Prospective evaluation of renal function in dogs with chronic mitral valve disease. bioRxiv: 2020.2003.2018.996785.
- Miyagawa Y, Takemura N, Hirose H. 2009. Evaluation of the measurement of serum cystatin C by an enzyme-linked immunosorbent assay for humans as a marker of the glomerular filtration rate in dogs. J Vet Med Sci 71: 1169-1176. https://doi.org/10.1292/jvms.71.1169
- Morgan KRS, Monteith G, Raheb S, Colpitts M, Fonfara S. 2020. Echocardiographic parameters for the assessment of congestive heart failure in dogs with myxomatous mitral valve disease and moderate to severe mitral regurgitation. Vet J 263: 105518.
- Nabity M, Lees G, Boggess M, Yerramilli M, Obare E, Yerramilli M, Rakitin A, Aguiar J, Relford R. 2015. Symmetric dimethylarginine assay validation, stability, and evaluation as a marker for the early detection of chronic kidney disease in dogs. J Vet Intern Med 29: 1036-1044.
- Oh SW, Han SY. 2015. Loop diuretics in clinical practice. Electrolyte Blood Press 13: 17-21. https://doi.org/10.5049/EBP.2015.13.1.17
- Pouchelon JL, Atkins CE, Bussadori C, Oyama MA, Vaden SL, Bonagura JD, Chetboul V, Cowgill LD, Elliot J, Francey T, Grauer GF, Fuentes VL, Moise NS, Polzin DJ, Dongen AMV, Israel NV. 2015. Cardiovascular-renal axis disorders in the domestic dog and cat: a veterinary consensus statement. J Small Anim Pract 56: 537-552. https://doi.org/10.1111/jsap.12387
- Ronco C, Haapio M, House AA, Anavekar N, Bellomo R. 2008. Cardiorenal syndrome. J Am Coll Cardiol 52: 1527-1539. https://doi.org/10.1016/j.jacc.2008.07.051
- Shlipak MG, Katz R, Kestenbaum B, Fried LF, Siscovick D, Sarnak MJ. 2009. Clinical and subclinical cardiovascular disease and kidney function decline in the elderly. Atherosclerosis 204: 298-303. https://doi.org/10.1016/j.atherosclerosis.2008.08.016
- Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, Siscovick DS, Stehman-Breen C. 2005. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 352: 2049-2060. https://doi.org/10.1056/NEJMoa043161
- Society IRI. 2023. IRIS staging of CKD. http://www.iriskidney.com.
- Zhao R, Li Y, Dai W. 2016. Serum Cystatin C and the risk of coronary heart disease in ethnic Chinese patients with normal renal function. Lab Med 47: 13-19. https://doi.org/10.1093/labmed/lmv004